AI SEC Filing Analysis — 2026-06-24

AIHIGH SIGNALFINANCIAL10-K

C3.ai reported a severe deterioration across all key financial metrics for the fiscal year ending June 2026, with revenue declining meaningfully and losses widening substantially, raising material concerns about business viability.

The combination of a revenue contraction exceeding 25% year-over-year and operating losses that widened substantially represents a serious negative inflection for the business, triggering multiple High-signal criteria simultaneously. Cash and equivalents declined by roughly 60%, compressing the company's liquidity runway at precisely the moment it needs capital to fund ongoing operating deficits. Investors should closely scrutinize management's path to profitability and whether the remaining cash position — just $66.2M — is sufficient to sustain operations without additional financing.

Comparing 2026-06-24 vs 2025-06-23View on EDGAR →

FINANCIAL ANALYSIS

Revenue declined meaningfully to $250.3M from $389.1M, while gross profit contracted sharply to $77.4M from $235.9M, suggesting significant pressure on the cost structure or pricing environment relative to the prior year. Net loss widened substantially to -$470.4M from -$288.7M, and operating loss deepened to -$498.5M from -$324.4M, indicating that expense levels are not scaling down in proportion to the revenue decline. The balance sheet reflects the strain, with total assets falling to $816.3M, stockholders' equity declining to $653.8M, and cash dropping to $66.2M — a materially reduced financial cushion that leaves limited margin for error as the company navigates this deterioration.

FINANCIAL STATEMENT CHANGES

Gross Profit

P&L

-67.2%

$235.9M→$77.4M

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Net Income

P&L

-62.9%

-$288.7M→-$470.4M

Net income declined 62.9% — review whether driven by operations, interest costs, or non-recurring items.

Cash & Equivalents

Balance Sheet

-59.7%

$164.4M→$66.2M

Cash declined 59.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Operating Income

P&L

-53.7%

-$324.4M→-$498.5M

Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.

Capital Expenditure

Cash Flow

-37.2%

$3.0M→$1.9M

Capex reduced 37.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Revenue

P&L

-35.7%

$389.1M→$250.3M

Revenue declined 35.7% — significant demand weakness or market share loss warrants investigation.

Accounts Receivable

Balance Sheet

-26.7%

$137.2M→$100.5M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Stockholders Equity

Balance Sheet

-22%

$838.3M→$653.8M

Equity decreased 22% — buybacks or losses reducing book value, monitor solvency ratios.

Current Assets

Balance Sheet

-21.7%

$904.3M→$708.0M

Current assets declined 21.7% — monitor working capital adequacy and short-term liquidity.

Total Assets

Balance Sheet

-20.4%

$1.0B→$816.3M

Total assets contracted 20.4% — asset sales, write-downs, or balance sheet optimization underway.

LANGUAGE CHANGES

NEW — 2026-06-24

PRIOR — 2025-06-23

ADDED

As of June 10, 2026, the registrant had outstanding 151,949,285 shares of Class A common stock and 3,499,992 shares of Class B common stock.

These forward-looking statements include, but are not limited to, statements concerning the following: our expectations regarding our revenue, expenses, and other operating results, including statements relating to the portion of our remaining performance obligations that we expect to be recognized as revenue in future periods our future financial performance, including expectations regarding our stock-based compensation; our ability to acquire new customers and successfully retain existing customers our expectations regarding our tax obligations and the realization of our U.S.

You should not rely on forward-looking statements as predictions of future events.

Sales to government entities and highly regulated organizations are subject to a number of challenges and risks, including U.S.

Because we derive substantially all of our revenue from subscriptions to our C3 AI Software and Center of Excellence support services, failure of Enterprise AI solutions in general and our C3 AI Software in particular to satisfy customer demands or to achieve increased market acceptance would adversely affect our business, results of operations, financial condition, and growth prospects.

Issues raised by the use of artificial intelligence (AI), including machine learning (ML), in our C3 Agentic AI Platform may result in reputational harm or liability or otherwise adversely affect our business, financial condition and results of operations.

Our current C3 AI Software, as well as applications, features, and functionality that we may introduce in the future, may not be widely accepted by our customers, may receive negative attention or may require us to compensate or reimburse third parties, any of which may lower our margins and harm our business.

Changes in our subscription or pricing models could adversely affect our operating results.

Our revenue depends in part on the success of our strategic relationships with third parties, including channel partners, and if we are unable to establish and maintain successful relationships with them, our business, operating results, and financial condition could be adversely affected.

We may not successfully execute or achieve the expected benefits of our restructuring plan and other measures we may take in the future, and our efforts may adversely affect our business.

REMOVED

As of June 2, 2025, the registrant had outstanding 130,885,934 shares of Class A common stock and 3,499,992 shares of Class B common stock.

If we were to lose the services of our Chief Executive Officer, or CEO, or other members of our senior management team, we may not be able to execute our business strategy.

Macroeconomic uncertainties have had, and could continue to have, an adverse impact on our business, our operations, and the markets and communities in which we, our partners, and users operate.

If our information technology systems or data, or those of third parties with whom we work, are or were compromised, we could experience adverse consequences resulting from such compromise, including, but not limited to, regulatory investigations or actions; litigation; fines and penalties; disruptions of our business operations; reputational harm; loss of revenue or profits; loss of customers or sales; and other adverse consequences.

Issues raised by the use of artificial intelligence, or AI, including machine learning, or ML, in our C3 Agentic AI Platform may result in reputational harm or liability or otherwise adversely affect our business, financial condition and results of operations.

Indemnity provisions in various agreements potentially expose us to substantial liability for intellectual property infringement and other losses.

C3 Generative AI is also available as a standalone capability deployable against customer datasets and software applications enabling customers to leverage large language models (LLMs) and domain-specific agents to retrieve data, analyze information, surface insights, and orchestrate workflows to drive business value.

We offer three primary families of software solutions, which we collectively refer to as our C3 AI software : The C3 Agentic AI Platform , our core technology, is a comprehensive, end-to-end application development and runtime environment that is designed to allow our customers to rapidly design, develop, and deploy Enterprise AI applications.

Our customers can use the C3 Agentic AI Platform to build and operate their own custom Enterprise AI applications and to customize, operate, and manage C3 AI Applications.

This provides significant benefits, including: Scale AI Across the Business.

SIGNAL HISTORY — AI

2025-06

2026-06

HighMediumLow

MORE FINANCIAL SIGNALS

CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...

2026-03-02

UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...

2026-03-02

PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...

2026-02-26